MedTrace Logo

Comparison of Pharmacokinetic Parameters Between Adopters of Electronic Cigarettes and a Historical Sample of Combustible Cigarette Smokers

NCT02730676 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2018-06-01

No results posted yet for this study

Summary

This study assesses the nicotine pharmacokinetic (PK) parameters in adopters of electronic cigarettes following a 12-hour tobacco and nicotine abstinence. The PK results of this study will be compared to historical data on smokers obtained in prior studies, as well as on naïve and short-term users of electronic cigarettes.

Conditions

  • Smoking

Interventions

OTHER

Electronic Cigarette #1

VUSE® Digital Vapor Cigarettes (original flavor, 29 mg nicotine)

OTHER

Electronic Cigarette #2

VUSE® Digital Vapor Cigarettes (menthol flavor, 29 mg nicotine)

Sponsors & Collaborators

  • Davita Clinical Research

    collaborator INDUSTRY

  • RAI Services Company

    collaborator INDUSTRY

  • R.J. Reynolds Vapor Company

    lead INDUSTRY

Principal Investigators

  • Robert Williams, MD · Davita Clinical Research

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02730676 on ClinicalTrials.gov